This provider averages 70 services per working day
Based on 52.6K total services over 3 years (250 working days/year). Learn about impossible service volumes →
This provider's $5.4M in total Medicare payments ranks in the 96th percentile of Ophthalmology providers nationally.
Averaging 70 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 122078% from 2021 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 24373% in 2022
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2021 | $5.4K | $130.83 | 41.37x | $5.3K | $3.7K | 28 | 1 |
| 2022 | $589.91 | $167.44 | 3.52x | $422.47 | $896.5K | 5.4K | 17 |
| 2023 | $329.43 | $94.88 | 3.47x | $234.55 | $4.5M | 47.2K | 25 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 3.7K | $2.6M | $695.83 | 2.58x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 30.9K | $898.3K | $29.07 | 2.75x |
| 67028 | Injection of drug into eye | 3.1K | $311.3K | $101.17 | 11.32x |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 1.6K | $274.6K | $170.59 | 2.93x |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 983 | $216.2K | $219.94 | 3.05x |
| J2778 | Injection, ranibizumab, 0.1 mg | 1.0K | $202.5K | $194.69 | 2.78x |
| 92134 | Imaging of retina | 5.5K | $175.7K | $32.07 | 4.68x |
| J3490 | Unclassified drugs | 61 | $122.2K | $2.0K | 3.94x |
| 92014 | Established patient complete exam of visual system | 995 | $94.3K | $94.73 | 4.75x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 825 | $91.1K | $110.43 | 4.33x |
| 92012 | Established patient problem focused exam of visual system | 940 | $65.1K | $69.24 | 4.72x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 393 | $48.7K | $124.00 | 4.55x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 294 | $46.6K | $158.66 | 2.34x |
| 92004 | New patient complete exam of visual system | 384 | $43.1K | $112.24 | 4.68x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 303 | $30.0K | $98.96 | 4.45x |
| J7999 | Compounded drug, not otherwise classified | 411 | $29.6K | $71.98 | 7.64x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 320 | $21.9K | $68.33 | 4.54x |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | 38 | $16.6K | $437.27 | 9.83x |
| 67228 | Destruction of leaking blood vessels of retina using laser | 56 | $15.5K | $276.69 | 5.26x |
| 67041 | Removal of membrane of retina | 16 | $15.3K | $955.30 | 5.02x |
This provider submits charges 3.51 times higher than what Medicare actually pays.
A markup ratio of 3.51x means for every $100 Medicare pays, this provider initially charges $351. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Nathan Steinle, M.D. | Santa Barbara, CA | $63.1M | ✓ Clear |
| Stephen Couvillion, MD | Santa Barbara, CA | $47.7M | ✓ Clear |
| Margaret Chang, M.D. | Sacramento, CA | $47.6M | ✓ Clear |
| David Boyer, MD | Los Angeles, CA | $47.5M | ✓ Clear |
| Alessandro Castellarin, M.D. | Santa Barbara, CA | $46.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data